| 1 |
23833659 | The radiation-sensitizing effect of flavopiridol in the esophageal cancer cell line Eca109. | 2013 Jun |
2 |
| 2 |
23839043 | Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity. | 2013 Aug 1 |
1 |
| 3 |
22558078 | Characterization of cyclin E expression in multiple myeloma and its functional role in seliciclib-induced apoptotic cell death. | 2012 |
1 |
| 4 |
19560490 | Flavopiridol reduces the impedance of neural prostheses in vivo without affecting recording quality. | 2009 Oct 15 |
1 |
| 5 |
18223228 | Rhabdoid tumor growth is inhibited by flavopiridol. | 2008 Jan 15 |
2 |
| 6 |
16479154 | Cyclin D1 overexpression increases the susceptibility of human U266 myeloma cells to CDK inhibitors through a process involving p130-, p107- and E2F-dependent S phase entry. | 2006 Feb |
1 |
| 7 |
16624404 | Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment. | 2006 Nov |
1 |
| 8 |
16905211 | Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases. | 2006 Aug |
1 |
| 9 |
15548426 | Cyclooxygenase-2 activity contributes to neuronal expression of cyclin D1 after anoxia/ischemia in vitro and in vivo. | 2004 Dec 6 |
2 |
| 10 |
15634644 | The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanism. | 2004 Dec |
1 |
| 11 |
12457721 | Flavopiridol, a cyclin dependent kinase (CDK) inhibitor, induces apoptosis by regulating Bcl-x in oral cancer cells. | 2003 Jan |
1 |
| 12 |
11956082 | Rate-limiting effects of Cyclin D1 in transformation by ErbB2 predicts synergy between herceptin and flavopiridol. | 2002 Apr 15 |
2 |
| 13 |
11978170 | Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development. | 2002 May |
1 |
| 14 |
12153166 | Seventy-two hour continuous infusion flavopiridol in relapsed and refractory mantle cell lymphoma. | 2002 Apr |
1 |
| 15 |
12241561 | HIV-1 expression induces cyclin D1 expression and pRb phosphorylation in infected podocytes: cell-cycle mechanisms contributing to the proliferative phenotype in HIV-associated nephropathy. | 2002 Sep 19 |
2 |
| 16 |
12479366 | Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways. | 2002 Jul |
2 |
| 17 |
10375610 | Induction of differentiation accompanies inhibition of Cdk2 in a non-small cell lung cancer cell line. | 1999 Jul |
1 |
| 18 |
10441105 | Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation In vivo after carotid injury in the rat. | 1999 Aug 10 |
1 |
| 19 |
10493518 | Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. | 1999 Sep 15 |
7 |
| 20 |
9802881 | Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. | 1998 Nov 1 |
1 |
| 21 |
9829756 | Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells. | 1998 Nov |
1 |
| 22 |
8674031 | Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. | 1996 Jul 1 |
1 |